|
- Alpha-1-fetoprotein measurement, serum - Allina Health
The following are considered to be normal results for this test: The multiple of the median (MoM) value is adjusted for maternal weight, race, diabetes mellitus, and twin pregnancy [2] Normal values are approximately 15% higher for blacks or African Americans than for whites [2]
- MAFP1 - Overview: Alpha-Fetoprotein (AFP), Single Marker Screen . . .
Prenatal screening for open neural tube defect This test is a screening assay to identify pregnancies that may have an increased risk for neural tube defects (NTD) A screen-positive result indicates that the calculated alpha-fetoprotein multiple of the median (MoM) is 2 50 or greater and may indicate an increased risk for NTD
- What Is the AFP MoM Normal Range in Pregnancy?
Several personal factors are integrated into the MoM calculation to establish a precise, adjusted normal range The most significant factor is the gestational age of the fetus; an inaccurate due date is a common reason for an unusual result Maternal weight is also included, as AFP can be diluted in the bloodstream of heavier individuals
- alpha-1-fetoprotein (AFP) [Multiple of the median, MOM] adjusted in . . .
AFP values in maternal serum: Maternal serum AFP values from 1,500 unaffected, singleton pregnancies expressed as the regressed median multiples of the regressed median (MOM) for gestational weeks 15 to 21 are shown in the table below:
- Maternal Serum Alpha-Fetoprotein in Normal Pregnancy at 11–13 Weeks . . .
Objective: To establish a reference distribution of maternal serum alpha-fetoprotein (AFP) at 11–13 weeks’ gestation and define the contribution of maternal variables that influence the measured concentration of AFP
- Alpha-Fetoprotein (AFP), Single Marker Screen, Maternal, Serum - Duke . . .
Multiple of the medians (MoM) are adjusted for maternal weight (to account for dilution effects in heavier mothers) The AFP is adjusted upward in IDD to account for lower values in diabetic pregnancies
- Alpha-fetoprotein and its value for predicting pregnancy outcomes – a . . .
Alpha-fetoprotein (AFP) concentrations can be determined from maternal serum (S-AFP), as a part of non-invasive settings, or from invasively acquired amnion fluid (AF-AFP)
- Alpha-Fetoprotein (AFP), Single Marker Screen, Maternal, Serum . . .
Multiple of the medians (MoM) are adjusted for maternal weight (to account for dilution effects in heavier mothers) The AFP is adjusted upward in IDD to account for lower values in diabetic pregnancies
|
|
|